Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data™ .

Erin M TallonMary Pat GallagherVincent S StaggsDiana FerroDeepa Badrinath MurthyOsagie EbekozienMikhail N KosiborodMarcus LindCamila Manrique-AcevedoChi-Ren ShyuMark A Clements

Published in: BMJ open (2023)

Risk of TTE during COVID-19 illness is substantially higher in patients with diabetes. Further, risk for TTEs is higher in those with T1DM versus T2DM. Confirmation of increased diabetes-associated clotting risk in future studies may warrant incorporation of diabetes status into SARS-CoV-2 infection treatment algorithms.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
atrial fibrillation
metabolic syndrome
deep learning
data analysis
replacement therapy